Report Highlights
The global market for ablation devices is estimated to increase from $6.5 billion in 2022 to reach $11.3 billion by 2027, at a compound annual growth rate (CAGR) of 11.8% from 2022 through 2027.
Report Includes
- 116 data tables and 33 additional tables
- An overview of the global market and technologies for ablation devices
- Estimation of the market size and analyses of global market trends, with data from 2019-2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential and quantification of ablation devices market based on technology, product category, therapeutic segment, procedure, and region
- Analysis of underlying technological, environmental, legal/regulatory, and political trends that may influence the size and nature of the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Comprehensive company profiles of the leading players of the industry, including Conmed, Siemens Healthineers, Medtronic Inc., Boston Scientific Corp., Olympus Corp., and Smith & Nephew
Report Scope
This research report analyzes the global ablation devices market by technologies, product categories, therapeutic segments, key procedures, and geographic regions. The report includes key technologies involved in thermal and nonthermal ablation techniques. It discusses the role of supply chain members, from manufacturers to surgeons. The report also has an in-depth analysis of key companies operating in the global ablation devices market. The in-depth patent analysis in the report identifies extensive technological trends across years and geographies such as the U.S., Europe, and Japan.
The ablation devices market is mainly segmented into thermal and nonthermal technologies. Thermal technologies are further segmented into electrical, radiation, radio frequency, light, ultrasound, microwave and hydrothermal. The nonthermal technology market is segmented into cryotherapy and hydromechanical. The ablation devices technology market is also segmented based on products offered. The market is geographically segmented into North America, Europe, Asia-Pacific and RoW. For market estimates, data has been provided for 2019, 2020, 2021 (which serves as the base year) and 2022, and forecasts for 2027 are given. The report also covers market share for major market players. It includes the company profiles of the major players with brief overviews about their business segments, financials, product portfolios, recent developments, and pipeline products. It also provides the impact of the COVID-19 pandemic on this market. Companies profiled in this report include Conmed, Siemens Healthineers, Medtronic Inc., Boston Scientific Corp., Olympus Corp., Smith & Nephew and others.
Report Synopsis
Report Metrics | Details | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||||||||||||
Forecast period considered | 2022-2027 | ||||||||||||||||||||||
Base year market size | $5.8 billion | ||||||||||||||||||||||
Market size forecast | $11.3 billion | ||||||||||||||||||||||
Growth rate | CAGR of 11.8% for the forecast period of 2022-2027 | ||||||||||||||||||||||
Units considered | $ Millions | ||||||||||||||||||||||
Segments covered | technology, product category, therapeutic segment, procedure, and region | ||||||||||||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||||||||||
Key Market Drivers |
|
||||||||||||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
- Increasing prevalence of cancer, cardiovascular, ophthalmology, orthopedic, gynecology, urology ablations procedures
- Technological advancements and innovations
- Growing aging population specially in Asia-Pacific region
- Increasing Government initiatives
- Collaborations and partnership with healthcare providers
- Less time, less damage, less blood loss characteristics of ablations devices
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for ablation devices reached $2.8 billion in 2015. The market should reach $3.1 billion in 2016 and $5.4 billion by 2021, growing at a compound annual growth rate (CAGR) of 11.6% from 2016 to 2021.
Report Includes
- An overview of the global market for ablation devices.
- Analyses of global market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- A breakdown of the market into segments such as types of technology, products, major market players, application, geography, and factors influencing demand.
- A look at factors inhibiting market growth such as pricing, reimbursement policies, and stringent regulatory impositions.
- Discussion covering the role of supply chain members from manufacturers to surgeons.
- Profiles of major players in the industry.
Report Highlights
The global market for ablation devices reached nearly 8.1 billion in 2012. This market is expected to grow to $8.8 billion in 2013 and $15.1 billion in 2018 with a compound annual growth rate (CAGR) of 11.3% for the five-year period, 2013 to 2018.
Report Includes
- An overview of the global market for ablation devices
- Analyses of global market trends, with data from 2012, estiamtes for 2013, and projections of compound annual growth rates (CAGRs) through 2018
- A breakdown of the market into segments such as types of technology, products, major market players, application, geography, and factors influencing demand
- A look at factors inhibiting market growth such as pricing, reimbursement policies, and stringent regulatory impositions
- Comprehensive company profiles of major players
Related Reports
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.
Global Market for Pain Management Drugs and Devices
The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.
Advanced Orthopedic Technologies, Implants and Regenerative Products
The global market for advanced orthopedic technologies, implants, and regenerative products is estimated to increase from $66.4 billion in 2023 to reach $84.8 billion by 2028, at a compound annual growth rate (CAGR) of 4.1% from 2023 through 2028.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More